Lung cancer is the most common cause of cancer-related death in Australia, with the highest burden of disease. Research is vital in order to increase our understanding of how to prevent cancer and improve approaches to treatment and care. To date, lung cancer research funding has not reflected the impact lung cancer has on our community.
The National Lung Cancer Program is therefore encouraging targeted lung cancer research as a funding partner in Cancer Australia’s Priority-driven Collaborative Cancer Research Scheme. Through this scheme, the National Lung Cancer Program hopes to fund at least two lung cancer research projects per year.
1. Research identifying barriers to timely and appropriate initial diagnosis and referral of people with suspected or definite lung cancer.
2. Research with a specific emphasis on addressing the diagnosis and impact of lung cancer on:
- Aboriginal and Torres Strait Islander peoples,
- people from regional, rural and remote locations, and
- people from cultural and linguistically diverse backgrounds
The National Centre for Gynaecological Cancers is a funding partner in Cancer Australia’s Priority-driven Collaborative Cancer Research Scheme. Consumers affected by gynaecological cancers were involved in the assessment of these research grants.
- View the applicants in the 2009 round offered funding by the National Centre for Gynaecological Cancers (PDF 5KB)
The Centre and its Advisory Group identified the following two priority areas for gynaecological cancer research in the 2010 round of the Priority-driven Collaborative Cancer Research Scheme:
1. Research into improving quality of life, supportive care, survivorship outcomes and continuity of care, during or following treatment, for women with gynaecological cancers.
2. Research into translating evidence into practice that will optimise outcomes for women with gynaecological cancers, including: prevention; diagnosis; treatment; management; and/or referral to multidisciplinary specialist gynaecological oncology care.